Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Smith Nephew ADR Representing 2 Ord Shs SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee... see more

NYSE:SNN - Post Discussion

Smith Nephew ADR Representing 2 Ord Shs > Div makes this attractive
View:
Post by prested on Oct 27, 2022 11:57am

Div makes this attractive

At todays price of $23.77 the yield is 4.4%. Not bad and definitely safe. Sterling has taken a pounding (no pun intended!), and that has to be part of the reason for the downward drift in SP. But, the new PM is likely to do a turn around in the economy and I suspect he will lose no time in doing it since they have a mandate for  2 years and he wants to have the economy on a more even keel by then. If the pound rises, so too will SNN. More of a buy than anything IMO. GLTAL
Comment by radcat on Oct 30, 2022 10:07am
I am a new shareholder. Bought my shares a few days before the Sept 29th, the ex-dividend date. What I liked about SNN was... Covid-19 was made public on Jan 25th 2020, SNN share price on Jan 26th 2020 closed at $50.57. The high for the past year Nov 5th 2021 was $37.15. Both past share prices make SNN + dividend seem like a bargain. We all saw our hospitals over capacity with ill covid patients ...more  
Comment by willyk3 on Oct 30, 2022 10:56am
Good for you rad. I filled my plate with SNN at slightly higher prices as I kept buying with each new low. Sitting tite now and as with many other stocks that are at multi year lows I am prepared to wait it out while I collect the divvy. Still not sure why Stryker doesn't have a swing at this gem while the US dollar is so high
Comment by radcat on Oct 30, 2022 11:15am
Since you are a Divi hound, check out Energy Transfer (ET). I have followed them since early 2022 when their share price was at $8.00 U.S. with a dividend of $0.62 U.S. The dividend has been raised each quarter since then. This pas week it was increased from $0.92 U.S. to $1.06. Management has stated they want the dividend back to Pre covid-19 level of $1.22. I believe that will happen when they ...more  
Comment by prested on Oct 31, 2022 12:17pm
Thanks for the suggestion Rad, Incredible volume today of over 12 millionnahsre before noon. Seems the only fly in the ointment may be the Dakota Access Pipeline which a court has ruled an environmental study must be carried out by The Army Corps of Engineers. Tempting.
Comment by radcat on Nov 01, 2022 8:21am
ET reports earnings today after the close. Ex-dividend date is Nov 3rd, money in your account Nov 21st. Share price is currently up 22 cents to $12.99 U.S. in the aftermarket... So do you think SNN is a possible take-over target at $24.00 range? I think it was Johnson and Johnson that took a run at them back in 2011. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities